Braemar Hotels & Resorts (BHR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 Oct, 2026Executive summary
Brancous seeks election of five directors to oversee the planned exit from Ashford’s advisory arrangement, remaining hotel sales and use of proceeds; the annual meeting is scheduled for December 21, 2026.
Brancous beneficially owns 650,010 common shares, or 0.9% of shares outstanding as of August 4, 2026.
Voting matters and shareholder proposals
Five directors will be elected for terms ending at the 2027 annual meeting; Brancous recommends voting for its five nominees and withholding votes from the opposing slate.
The ballot also seeks ratification of BDO USA, P.C. for FY2026 and an advisory vote on named executive officer compensation; Brancous makes no recommendation on either.
Voters may select up to five candidates across both slates; Brancous says a contested election is decided by plurality, while its nomination validity remains disputed.
Brancous says its nomination notice was timely and materially complete, submitted a supplement on October 7, 2026, and may seek court relief to ensure its nominees are eligible.
Board of directors and corporate governance
The five nominees are Oliver Corlette, Ronald Davies, Andrew Fleiss, Michael Litwin and Alejandro Malbran; if all are elected, they would form a Board majority.
The nominees cite hospitality real estate, REIT operations, audit and risk committee service, private equity, financial reporting and stockholder advocacy experience.
Brancous advocates an independent review of strategy, remaining assets, advisory termination economics and documentation, capital allocation, Board independence, accountability and management structure.
The Board announced that it would end the Ashford advisory arrangement, become self-managed, add five independent directors and retain only Richard Stockton among current directors at termination.
Latest events from Braemar Hotels & Resorts
- Self-management and a seven-hotel luxury focus target $88M midpoint 2027 Adjusted EBITDAre.BHR
Investor presentation - Settlement ends the proxy challenge and imposes a 10-year standstill and shared costs.BHR
Proxy filing - Record RevPAR and EBITDA growth in Q2 2026, led by luxury resorts and major asset sales.BHR
Q2 2026 - Transition to self-management and board overhaul gains investor backing amid governance scrutiny.BHR
Proxy filing - Record AFFO per share, strong EBITDA growth, and a $176M asset sale highlight Q1 2026.BHR
Q1 2026 - 2025 saw modest RevPAR growth, net loss, and a sale process, with resorts outperforming.BHR
Q4 2025 - Urban hotels outperformed as asset sales and refinancing strengthened the balance sheet.BHR
Q2 2024 - Q1 2025 delivered 4.2% RevPAR growth, EBITDA gains, and key debt refinancing.BHR
Q1 2025 - Q4 RevPAR rose 1.9% with strong bookings and a positive 2025 outlook.BHR
Q4 2024